RHUMBLINE ADVISERS - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 135 filers reported holding ANIKA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$484,945
-63.9%
26,031
-49.7%
0.00%
-50.0%
Q2 2023$1,343,503
+94713.2%
51,713
+4.8%
0.00%0.0%
Q1 2023$1,417
+4.5%
49,322
+7.6%
0.00%0.0%
Q4 2022$1,356
-99.9%
45,825
+1.1%
0.00%0.0%
Q3 2022$1,079,000
+10.3%
45,317
+3.4%
0.00%
+100.0%
Q2 2022$978,000
-9.5%
43,815
+1.8%
0.00%0.0%
Q1 2022$1,081,000
-28.2%
43,056
+2.4%
0.00%
-50.0%
Q4 2021$1,506,000
-16.4%
42,043
-0.7%
0.00%0.0%
Q3 2021$1,802,000
-11.1%
42,350
-9.6%
0.00%
-33.3%
Q2 2021$2,027,000
-2.0%
46,824
-7.7%
0.00%0.0%
Q1 2021$2,069,000
-5.8%
50,726
+4.5%
0.00%0.0%
Q4 2020$2,197,000
+42.1%
48,545
+11.1%
0.00%
+50.0%
Q3 2020$1,546,000
-12.1%
43,691
-6.2%
0.00%
-33.3%
Q2 2020$1,758,000
+21.2%
46,584
-7.1%
0.00%0.0%
Q1 2020$1,450,000
-41.3%
50,146
+5.3%
0.00%
-25.0%
Q4 2019$2,470,000
+0.2%
47,639
+6.1%
0.00%
-20.0%
Q3 2019$2,464,000
+40.7%
44,883
+4.1%
0.01%
+66.7%
Q2 2019$1,751,000
+36.2%
43,118
+1.4%
0.00%
+50.0%
Q1 2019$1,286,000
-9.2%
42,538
+0.9%
0.00%
-33.3%
Q4 2018$1,417,000
-6.9%
42,172
+16.8%
0.00%0.0%
Q3 2018$1,522,000
+32.7%
36,092
+0.7%
0.00%
+50.0%
Q2 2018$1,147,000
-31.9%
35,848
+5.8%
0.00%
-50.0%
Q1 2018$1,684,000
-5.9%
33,876
+2.1%
0.00%0.0%
Q4 2017$1,789,000
+8.8%
33,181
+17.1%
0.00%0.0%
Q3 2017$1,644,000
+20.2%
28,345
+2.3%
0.00%
+33.3%
Q2 2017$1,368,000
+14.0%
27,720
+0.3%
0.00%0.0%
Q1 2017$1,200,000
+25.9%
27,624
+42.0%
0.00%
+50.0%
Q4 2016$953,000
+5.2%
19,455
+2.7%
0.00%0.0%
Q3 2016$906,000
-4.4%
18,935
+7.2%
0.00%
-33.3%
Q2 2016$948,000
+14.1%
17,670
-4.9%
0.00%0.0%
Q1 2016$831,000
+21.1%
18,575
+3.3%
0.00%
+50.0%
Q4 2015$686,000
+28.5%
17,990
+7.2%
0.00%0.0%
Q3 2015$534,000
-2.6%
16,780
+1.2%
0.00%0.0%
Q2 2015$548,000
-19.4%
16,589
+0.5%
0.00%0.0%
Q1 2015$680,000
+15.3%
16,514
+14.0%
0.00%0.0%
Q4 2014$590,000
+8.5%
14,489
-2.4%
0.00%0.0%
Q3 2014$544,000
-18.4%
14,839
+3.1%
0.00%0.0%
Q2 2014$667,000
+8.6%
14,389
-3.8%
0.00%0.0%
Q1 2014$614,000
+3.5%
14,950
-3.8%
0.00%0.0%
Q4 2013$593,000
+90.7%
15,540
+19.6%
0.00%
+100.0%
Q3 2013$311,000
+40.7%
12,990
+0.1%
0.00%0.0%
Q2 2013$221,00012,9720.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders